Predictors of maternal pertussis vaccination acceptance among pregnant women in Norway

Bo T. Hansen,Brita A. Winje,Jeanette Stålcrantz,Margrethe Greve-Isdahl

DOI: https://doi.org/10.1080/21645515.2024.2361499

2024-06-08

Human Vaccines & Immunotherapeutics

Abstract:Maternal vaccination against pertussis is safe and provides effective protection against pertussis for the newborn, but the vaccine coverage rate remains generally low. Norway is currently planning for introduction of routine maternal pertussis vaccination. To assess maternal pertussis vaccination acceptance among pregnant Norwegian women, we surveyed women at 20–40 weeks gestation in 2019. Among the 1,148 pregnant women participating in this cross-sectional study, 73.8% reported they would accept pertussis vaccination during pregnancy if it was recommended, 6.9% would not accept and 19.2% were undecided. Predictors for low likelihood of accepting pertussis vaccination during pregnancy included low confidence in health authorities and in maternal pertussis vaccination safety and effectiveness, low awareness and adherence to influenza vaccination during pregnancy, and low awareness of pertussis vaccination. The major reasons reported for not accepting or being undecided about maternal pertussis vaccination were lack of information on vaccine safety for both mother and child. Most women reported that they would consult their general practitioner or a midwife for information if they were offered maternal pertussis vaccination. General practitioners and midwives were also regarded as the most trustworthy sources of information if the women were in doubt about accepting vaccination. We conclude that information addressing safety concerns and raising awareness about maternal pertussis vaccination could increase acceptance of maternal pertussis vaccination. Our findings highlight the pivotal role of the antenatal and primary health care services in providing such information to pregnant women.

immunology,biotechnology & applied microbiology

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to explore the acceptance of pertussis vaccination among pregnant women in Norway and the factors influencing it. Specifically, the research objectives include:

1. **Assessing the willingness of pregnant women in Norway to accept pertussis vaccination**: Understanding whether pregnant women are willing to accept the pertussis vaccine when it is recommended.
2. **Identifying key factors influencing pregnant women's acceptance of pertussis vaccination**: Analyzing which factors increase or decrease the likelihood of pregnant women accepting the vaccine, with a particular focus on trust, safety perception, and vaccine efficacy perception.
3. **Understanding the reasons for non-acceptance or hesitation among pregnant women**: Investigating the main concerns and information needs of those who are unwilling or unsure about accepting the vaccine.
4. **Determining the preferred sources of information for pregnant women**: Understanding the most trusted sources of information for pregnant women when considering whether to accept the vaccine, to develop effective information dissemination strategies.

### Research Background

Pertussis is a serious health issue, particularly with a high disease burden for infants. Although the current vaccine cannot directly protect newborns, maternal vaccination during pregnancy can effectively protect newborns through the placental transfer of antibodies. Norway plans to introduce routine pertussis vaccination during pregnancy in 2024, so understanding pregnant women's willingness to accept the vaccine and the factors influencing it is crucial for policy formulation and implementation.

### Main Findings

- **Willingness to Accept**: Among the 1,148 pregnant women surveyed, 73.8% indicated they would accept the pertussis vaccine if recommended; 6.9% said they would not accept it; 19.2% were unsure.
- **Influencing Factors**:
- **Trust**: Low trust in health authorities is a significant barrier to vaccine acceptance. Pregnant women with low trust are significantly less likely to accept the vaccine.
- **Safety Perception**: Concerns about vaccine safety are one of the main worries. Pregnant women who believe the vaccine may increase the risk of birth defects or complicated pregnancies are less likely to accept it.
- **Vaccine Efficacy Perception**: Lack of confidence in the vaccine's effectiveness is also a factor influencing acceptance.
- **History of Other Vaccinations**: Pregnant women who have not received the influenza vaccine or are unaware of the influenza vaccine recommendations are less likely to accept the pertussis vaccine.
- **Information Needs**: The most needed information for pregnant women includes the side effects of the vaccine on the fetus/child and the impact of pertussis on children.
- **Sources of Information**: The most trusted sources of information for pregnant women are midwives and general practitioners, followed by health authority websites.

### Conclusion

The study results indicate that increasing pregnant women's awareness of the safety and effectiveness of the pertussis vaccine, enhancing trust in health authorities, and providing relevant information through reliable channels can increase the willingness of pregnant women to accept the pertussis vaccine. These findings highlight the critical role of prenatal and primary care services in providing such information.